56 related articles for article (PubMed ID: 1470566)
1. Effects of peptide YY on pancreatic blood flow and oxygen consumption.
Pawlik WW; Gustaw P; Sendur R; Czarnobilski K; Hottenstein OD; Konturek SJ
Pol J Pharmacol Pharm; 1992; 44(3):289-98. PubMed ID: 1470566
[TBL] [Abstract][Full Text] [Related]
2. [The role of cholecystokinin receptors in the regulation of the circulation and oxygen consumption in the pancreas].
Gustaw P; Samborska M; Pawlik WW; Konturek SJ
Folia Med Cracov; 1990; 31(1-2):45-56. PubMed ID: 2210484
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide as mediator of bradykinin-induced pancreatic circulatory and metabolic responses.
Pawlik WW; Sendur R; Biernat J; KozioĊ R
J Physiol Pharmacol; 1997 Dec; 48(4):751-60. PubMed ID: 9444622
[TBL] [Abstract][Full Text] [Related]
4. Role of nitric oxide in the pancreatic vascular and metabolic responses associated with activation of capsaicin-sensitive neurons.
Pawlik WW; Czarnobilski K; Sendur R; Konturek SJ
J Physiol Pharmacol; 1996 Dec; 47(4):601-9. PubMed ID: 9116327
[TBL] [Abstract][Full Text] [Related]
5. Experimental studies on the interrelationship between organs mediated by peptide YY: effect on splanchnic circulation and exocrine pancreas in dogs.
Sumi S; Inoue K; Tobe T
Nihon Geka Hokan; 1990 May; 59(3):224-33. PubMed ID: 2130785
[TBL] [Abstract][Full Text] [Related]
6. Adrenergic pathway in the inhibition of pancreatic secretion by peptide YY in dogs.
Konturek SJ; Bilski J; Pawlik W; Tasler J; Domschke W
Gastroenterology; 1988 Feb; 94(2):266-73. PubMed ID: 3335306
[TBL] [Abstract][Full Text] [Related]
7. The effect of pancreatic polypeptide and peptide YY on pancreatic blood flow and pancreatic exocrine secretion in the anesthetized dog.
DeMar AR; Lake R; Fink AS
Pancreas; 1991 Jan; 6(1):9-14. PubMed ID: 1994383
[TBL] [Abstract][Full Text] [Related]
8. Peptide YY inhibits pancreatic secretion via cholinergic pathways.
Brodish RJ; Kuvshinoff BW; Fink AS; McFadden DW
J Surg Res; 1993 Jul; 55(1):103-8. PubMed ID: 8105149
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic peptide YY mRNA levels increase during adaptation after small intestinal resection.
Liu CD; Hines OJ; Whang EE; Laird EC; Skotzko MJ; Zinner MJ; Ashley SW; McFadden DW
J Surg Res; 1995 Jan; 58(1):6-11. PubMed ID: 7830408
[TBL] [Abstract][Full Text] [Related]
10. Peptide YY antagonizes beta-adrenergic-stimulated release of insulin in dogs.
Greeley GH; Lluis F; Gomez G; Ishizuka J; Holland B; Thompson JC
Am J Physiol; 1988 Apr; 254(4 Pt 1):E513-7. PubMed ID: 2895586
[TBL] [Abstract][Full Text] [Related]
11. Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1.
Liu CD; Balasubramaniam A; Saxton RE; Paiva M; McFadden DW
J Surg Res; 1995 Jun; 58(6):707-12. PubMed ID: 7791350
[TBL] [Abstract][Full Text] [Related]
12. Adrenergic pathways do not mediate peptide YY-induced inhibition of pancreatic exocrine secretion.
Brodish RJ; Kuvshinoff BW; McFadden DW; Fink AS
Pancreas; 1995 Mar; 10(2):187-93. PubMed ID: 7716143
[TBL] [Abstract][Full Text] [Related]
13. Effects of peptide YY on dog and rat pancreatic secretion in vivo and in vitro.
Bilski J; Hladij M; Jaworek J; Konturek SJ; Varga G
Int J Pancreatol; 1988 Jul; 3(5):309-21. PubMed ID: 2459272
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory action of peptide YY on pancreatic secretion is independent of secretin.
Lluis F; Gomez G; Greeley GH; Thompson JC
Biol Signals; 1992; 1(2):88-93. PubMed ID: 1307917
[TBL] [Abstract][Full Text] [Related]
15. Postprandial peptide YY release is mediated by cholecystokinin.
McFadden DW; Rudnicki M; Kuvshinoff B; Fischer JE
Surg Gynecol Obstet; 1992 Aug; 175(2):145-50. PubMed ID: 1636140
[TBL] [Abstract][Full Text] [Related]
16. Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice.
van den Hoek AM; Heijboer AC; Voshol PJ; Havekes LM; Romijn JA; Corssmit EP; Pijl H
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E238-45. PubMed ID: 16940471
[TBL] [Abstract][Full Text] [Related]
17. The pancreas and oxygen consumption. 1. Pancreatic oxygen consumption in normo- and hypovolemic dogs.
Robert JH; Toledano AE; Huang G; Toth LS; Premus G; Papp M; Dreiling DA
Int J Pancreatol; 1989 Feb; 4(1):51-63. PubMed ID: 2926179
[TBL] [Abstract][Full Text] [Related]
18. Peptide YY attenuates STAT1 and STAT3 activation induced by TNF-alpha in acinar cell line AR42J.
Robinson K; Vona-Davis L; Riggs D; Jackson B; McFadden D
J Am Coll Surg; 2006 May; 202(5):788-96. PubMed ID: 16648019
[TBL] [Abstract][Full Text] [Related]
19. Effect of natural peptide YY on blood flow and exocrine secretion of pancreas in dogs.
Inoue K; Hosotani R; Tatemoto K; Yajima H; Tobe T
Dig Dis Sci; 1988 Jul; 33(7):828-32. PubMed ID: 3378477
[TBL] [Abstract][Full Text] [Related]
20. Effects of intraluminal peptide YY on pancreatic function.
Brodish RJ; Kuvshinoff BW; Fink AS; McFadden DW
Int J Pancreatol; 1992 Oct; 12(2):153-60. PubMed ID: 1460330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
